March 29, 2026 12:34 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Modi says govt taking steps to shield Indians from impact of Middle East crisis | Bengal polls a ‘fight for liberation from fear’, says Amit Shah as he unveils TMC chargesheet | ‘Won’t mix politics with sport’: Bangladesh lifts IPL broadcast ban | ‘Feeling blessed’: PM Modi attends Surya Tilak ceremony at Ayodhya Ram Temple virtually | ‘No lockdown’: Union Minister Hardeep Singh Puri dismisses rumours, assures preparedness amid West Asia tensions | Middle East crisis: Govt cuts excise duty by Rs 10 on petrol and diesel, giving big relief amid global oil shock | ‘Big boost for NCR connectivity’: PM Modi to inaugurate Noida International Airport Phase 1 tomorrow | HDFC chairman Atanu Chakraborty resigned over power struggle with CEO Sashidhar Jagdishan: Report | PM Modi to chair meeting with CMs tomorrow amid West Asia conflict | ‘I said, no thanks’: Trump claims Iran offered him Supreme Leader role
Serum Institute of India

SII buys 50 pc stake in pharma packaging firm Schott Kaisha

| @indiablooms | Aug 18, 2021, at 06:41 am

Pune/IBNS: Pune-based manufacturer of AstraZeneca vaccine, Covishield, Serum Institute of India (SII) has acquired a 50 per cent stake in SCHOTT Kaisha to become SCHOTT's joint venture partner and secure the pharma packaging supply, the pharma company announced on Tuesday.

"Securing supply chain is of strategic importance...As a longtime customer, we use their vials, ampoules and syringes to store vaccines, including Covishield" CEO Adar Poonawalla said in his statement.

SCHOTT is the manufacturer of the glass vials to the coronavirus vaccine manufacturer across the globe.

Kairus Dadachanji and Shapoor Mistry were the former co-owners of the Indian joint venture SCHOTT Kaisha.

Dr Frank Heinricht, CEO of SCHOTT said, "As India has steadily established its position as a global pharmaceutical hub, we are delighted to strengthen our footprint within the Indian pharma supply chain. We are looking forward to strong impulses from this partnership."

Eric L'Heureux, the new managing director and former longstanding head of operations with the venture said, "We have significantly increased our production capacity in India. Over the last three years, we have invested roughly Rs 600 crores to set up two new plants in Gujarat's Umarsadi and Himachal Pradesh's Baddi, and to secure uninterrupted supply in our existing facilities during the pandemic."

The fact that SCHOTT has an integrated value chain, covering also the glass tubing the packaging is made of, further helped to secure the supply chain.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Related Videos
RBI announces repo rate cut Jun 06, 2025, at 10:51 am
FM Nirmala Sitharaman presents Budget 2025 Feb 01, 2025, at 03:45 pm
Nirmala Sitharaman on Budget 2024 Jul 23, 2024, at 09:30 pm